Clinical Research Directory
Browse clinical research sites, groups, and studies.
Cryopreserved Ovarian Tissue Transplantation in Patients Who Have Survived Sarcomas and Hematological Tumors
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The study aims to test for the presence or absence of primary tumor-specific tumor markers in ovarian tissue. Therefore, there will be a first phase in which pathology-specific markers will be identified in the patients' diagnostic pathological material by histological, immunohistochemical, and molecular analysis; then, tumor markers will be sought in cryopreserved ovarian tissue.
Official title: Safety Assessment Of Cryopreserved Ovarian Tissue Transplantation In Patients Who Have Survived Sarcomas And Hematological Tumors
Key Details
Gender
FEMALE
Age Range
18 Years - 38 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2024-08-12
Completion Date
2026-08-12
Last Updated
2025-02-17
Healthy Volunteers
No
Conditions
Interventions
Step 1
Cryopreservation of ovarian tissue
Step 2
Analysis of tumor markers in the primary tumor
Step 3
Search for neoplastic cells in cryopreserved ovarian tissue
Step 4
Cryopreserved ovarian tissue autotransplantation
Locations (1)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy